Distinct sensitivity of neuroblastoma cells for retinoid receptor agonists: Evidence for functional receptor heterodimers

Oncogene

Volumn 15, Issue 15, 1997, Pages 1805-1813

  Carpentier, Antoine ^a   Balitrand, Nicole ^a   Rochette Egly, Cécile ^b   Shroot, Braham ^c   Degos, Laurent ^d   Chomienne, Christine ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c Galderma R and D   (France)

^d SAINT LOUIS HOSPITAL   (France)

Author keywords

Neuroblastoma; Retinoic acid; Retinoic acid receptor; Retinoid receptor agonist

Indexed keywords

CELL EXTRACT; DIMER; MESSENGER RNA; MONOCLONAL ANTIBODY; RECEPTOR SUBTYPE; RECEPTOR SUBUNIT; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID;

ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEUROBLASTOMA CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

EID: 0030697461     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201335     Document Type: Article

References (51)

1. Berard J, Gaboury L, Landers M, De Repentigny Y, Houle B, Kothary R and Bradley WE. (1994). EMBO J., 13, 5570-5580.
2. Brodeur GM and Nakagawara A. (1992). Am. J. Pediatry. Hematol. Oncol., 14, 111-116.
3. Calabresse C, Barbey S, Venturini L, Balitrand N, Degos L, Fenaux P, Chomienne C. (1995). Leukemia, 9, 2049-2057.
4. Carney DN and De Leij L. (1988). Semin. Oncol., 15, 199-214.
5. Castle VP, Ou X, O'Shea S and Dixit VM. (1992). J. Clin. Invest., 90, 1857-1863.
6. Chen Z, Guidez F, Rousselot P, Agadir A, Chen SJ, Wang ZY, Degos I, Waxman S, Zelent A and Chomienne C. (1994). Proc. Natl. Acad. Sci., 91, 1178-1182.
7. Chen JY, Clifford J, Zusi C, Starrett J, Tortolani D, Ostrowski J, Reczek PR, Chambon P and Gronemeyer H. (1996). Nature, 382, 819-822.
8. Chirgwin JM, Przybyla AE, MacDonald RJ and Rutter WJ. (1979). Biochemistry, 18, 5294.
9. Chomienne C, Balitrand N, Ballerini P, Castaigne S, De Thé H and Degos L. (1991). J. Clin. Invest., 88, 2150-2154.
10. Collins SJ, Robertson KA and Mueller L. (1990). Mol. Cell. Biol., 10, 2154-2163.
11. De Luca LM. (1991). FASEB J., 5, 2924-2933.
12. De Thé H, Marchio A, Tiollais P and Dejean A. (1989). EMBO J., 8, 429-433.
13. De Thé H, Chomienne C, Lanotte M, Degos L and Dejean A. (1990). Nature (London), 347, 558-561.
14. Evans AE, D'Angio GJ and Randolph J. (1971). Cancer, 27, 374-378.
15. Finklestein JZ, Krailo MD, Lenarsky C et al. (1992). Med. Ped. Oncol., 20, 307-311.
16. Gaub MP, Rochette-Egly C, Lutz Y, Ali S, Matthes H, Scheuer I and Chambon P. (1992). Exp. Cell Res., 201, 335-346.
17. Grignagni F, Ferruci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Grignani F, Peschle C, Nicolleti L and Pellici PG. (1993). Cell, 74, 423-431.
18. Gudas LJ. (1992). Cell Growth Diff., 3, 655-662.
19. Gudas LJ, Sporn MB and Roberts AB. (ed) (1994). The retinoids: Cellular Biology and Biochemistry of the Retinoids. Raven Press: New York, pp 443-520.
20. Higuchi T, Hannigan GE, Malkin D, Yeger H and Williams BR. (1991). Cancer Res., 1, 3958-3964.
21. Hu L and Gudas L. (1990). Mol. Cell Biol., 19, 391-396.
22. Kastner P, Mark M and Chambon P. (1995). Cell, 15, 859-869.
23. Lala DS, Mukherjee R, Schulman IG, Koch SSC, Dardashti LJ, Nadzan AM, Croston GE, Evans RM and Heyman RA. (1996). Nature, 383, 450-453.
24. Leid M, Kastner P and Chambon P. (1992). Trends Biochem. Sci., 176, 427-433.
25. Leroy P, Nakshatri H and Chambon P. (1991). Proc. Nat. Acad. Sci. USA, 87, 4804-4808.
26. Li C, Einhorn PA and Reynolds CP. (1994). Progress in Clin. Biol. Research, 385, 221-227.
27. Lovat PE, Pearson ADJ, Malcolm A and Redfern CPF. (1993). Neurosci Lett., 162, 109-113.
28. Mader S, Chen JY, Chen Z, White J, Chambon P and Gronemeyer H. (1993). EMBO J., 15, 5029-5041.
29. Mangelsdorf DJ, Borgmeyer U, Heyman RA, Zhou JY, Ong ES, Oro AE, Kakizuka A and Evans RM. (1992). Genes and Development, 6, 329-344.
30. Mangelsdorf DJ and Evans RM. (1995). Cell, 83, 841-850.
31. Manohar CF, Salwen HR, Furtado MR and Cohn SL. (1996). Tumour Biology, 17, 34-47.
32. Marshall GM, Cheung B, Stacey KP, Norris MD and Haber M. (1993). Anticancer Res., 13, 437-442.
33. Marshall GM, Cheung B, Stacey KP, Camacho ML, Simpson AM, Kwan E, Smith S, Haber M and Norris MD. (1995). Oncogene, 11, 485-491.
34. Nervi C, Vollberg TM, Grippo JF, Lucas DA, George MD, Sherman MI, Shudo K and Jetten AM. (1990). Cell Growth Diff., 1, 535-542.
35. Plum LA and Clagett-Dame M. (1995). Arch. Biochem. Biophys., 319, 457-463.
36. Redfern CPF, Lovat PE, Malcolm AJ and Pearson ADJ. (1994). Biochem. J., 304, 147-154.
37. Rees J, Daly A and Redfern C. (1989). Biochem. J., 259, 917-919.
38. Reynolds CP, Schindler PF, Jones DM, Gentile JL, Proffitt RT and Einhorn PA. (1994). Advances in Neuroblastoma Research. Evans AE, Biedler JL, Brodeur GM (eds). Wiley-Liss: New York, 4, 237-244.
39. Rochette-Egly C, Gaub MP, Lutz Y, Ali S, Scheuer I, Chambon P. (1992). Mol. End., 6, 2197-2209.
40. Rochette-Egly C, Lutz Y, Pfister V, Heyberger S, Scheuer I, Chambon P, Gaub MP. (1994). B.B.R.C., 525-536.
41. Rosolen A, Colomonici OR, Pfeffer LM, Whitesell L, Nordan R and Nekers LM. Eur. Cytokine Netw. (1992), 2, 81-88.
42. Ross RA, Spengler BA, Biedler JA. (1983). J. Natl. Cancer Inst., 71, 741-747.
43. Rousselot P, Hardas B, Castaigne S, Dejean A, De Thé H, Degos L, Farzaneh F, Chomienne C. (1994). Oncogene, 9, 545-551.
44. Roy B, Taneja R, Chambon P. (1995). Mol. Cell Biol., 15, 6481-6487.
45. Ruberte E, Dolle P, Chambon P, Morriss-Kay G. (1991). Development, 111, 45-60.
46. Sidell N. (1982). J.N.C.I., 68, 589-596.
47. Sidell N, Altman A, Haussler MR, Seeger RC. (1983). Exp. Cell Res., 148, 21-30.
48. Smith MA, Adamson PC, Balis FM, et al. (1992). J. Clin. Oncol., 10, 1666-1673.
49. Taneja R, Bouillet P, Boylan JF, Gaub MP, Roy B, Gudas L, Chambon P. (1995). Proc. Natl. Acad. Sci. USA, 92, 7854-7858.
50. Villablanca JG, Khan AA, Avramis VI, Seeger RC, Matthay KK, Ramsay NKC, Reynolds CP. (1995). J. Clin. Oncol., 13, 894-901.
51. Wuarin L, Chang B, Wada R, Sidell N. (1994). Int. J. Cancer, 15, 840-845.